K191953: ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL) (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K191953 (ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL), cleared 2019-08-22 for Biomerieux S.A.) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K191953 |
| Cleared Device Trade / Generic Name | ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL) |
| FDA Applicant on Filing | Biomerieux S.A. |
| FDA 3-Letter Product Classification | Product Code JWY |
| FDA Substantial Equivalence Decision Date | 2019-08-22 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Inspect consolidated manufacturer lineage at Biomerieux S.A., compare peer devices under FDA Product Code JWY, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.